Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 5/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | CASP6 | P55212 | 1/20 | 0.44 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.44 |
| ▸ | ABAT | P80404 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16974400 | 0.86 | GPR35 (0.60) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| SCHEMBL4958698 | 0.86 | GPR35 (0.60) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| SCHEMBL145978 | 0.84 | GPR35 (0.67) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| SCHEMBL29652066 | 0.84 | GPR35 (0.54) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| SCHEMBL888475 | 0.83 | GPR35 (0.64) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL6372499 | 0.83 | GPR35 (0.64) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| SCHEMBL29533001 | 0.83 | GPR35 (0.59) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| SCHEMBL17512851 | 0.83 | GPR35 (0.64) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| SCHEMBL28638066 | 0.83 | GPR35 (0.64) | GPR35HPGDTSHRTP53SMN1; SMN2 | |
| SCHEMBL27270155 | 0.83 | GPR35 (0.64) | GPR35HPGDTSHRTP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580776-B2 | Compositions and methods for treating neurodegenerating diseases | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2013-11-12 | — | — | US | claimed |
| US-20120296122-A1 | FLUOROETHER-FUNCTIONALIZED AMINOAROMATIC COMPOUNDS AND DERIVATIVES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-22 | — | — | US | claimed |
| US-20120296123-A1 | FLUOROETHER-FUNCTIONALIZED NITROAROMATIC COMPOUNDS AND DERIVATIVES THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-22 | — | — | US | claimed |
| WO-2012158303-A2 | FLUOROETHER-FUNCTIONALIZED AMINOAROMATIC COMPOUNDS AND DERIVATIVES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-11-22 | — | — | WO | claimed |
| US-20110086845-A1 | Compositions and Methods for Treating Neurodegenerating Diseases | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-04-14 | — | — | US | claimed |
| WO-1998059016-A1 | COMPOSITION AND METHOD FOR INHIBITING RADICAL POLYMERISATION OF ETHYLENICALLY UNSATURATED AROMATIC MONOMERS | RHODIA CHIMIE (FR) | 1998-12-30 | — | — | WO | claimed |
| US-4210498-A | CAMMA-PYRONES, NITRATED CATECHOLS, AND FLAVONES AS CHELATING AGENTS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1980-07-01 | — | — | US | claimed |
| US-12473454-B2 | Water-based extrusion primer for polyethylene | HENKEL AG & CO. KGAA (DE) | 2025-11-18 | — | — | US | disclosed |
| US-12227668-B2 | Use of preformed reaction products of catechol compounds and functionalized co-reactant compounds to reduce oxidation of bare metal surfaces | HENKEL AG & CO. KGAA (DE) | 2025-02-18 | — | — | US | disclosed |
| US-20240254317-A1 | DOPANT SOLUTION FOR CONDUCTIVE POLYMER, MONOMER LIQUID FOR PRODUCING CONDUCTIVE POLYMER, CONDUCTIVE COMPOSITION AND METHOD FOR PRODUCING SAME, AND ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING SAME | TAYCA CORPORATION (JP) | 2024-08-01 | — | — | US | disclosed |
| EP-3559312-B1 | REACTION PRODUCTS OF CATECHOL COMPOUNDS AND FUNCTIONALIZED CO-REACTANT COMPOUNDS FOR METAL PRETREATMENT APPLICATIONS | HENKEL AG & CO KGAA (DE) | 2024-04-24 | — | — | EP | disclosed |
| EP-3558667-B1 | TREATMENT OF CONVERSION-COATED METAL SUBSTRATES WITH PREFORMED REACTION PRODUCTS OF CATECHOL COMPOUNDS AND FUNCTIONALIZED CO-REACTANT COMPOUNDS | HENKEL AG & CO KGAA (DE) | 2024-03-20 | — | — | EP | disclosed |
| US-11891534-B2 | Treatment of conversion-coated metal substrates with preformed reaction products of catechol compounds and functionalized co-reactant compounds | HENKEL AG & CO. KGAA (DE) | 2024-02-06 | — | — | US | disclosed |
| US-5439570-A | Destroying tumors, viruses; magnetic resonance imaging | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-08-08 | — | — | US | disclosed |
| US-5432171-A | Water soluble texaphyrin metal complexes for viral deactivation | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-07-11 | — | — | US | disclosed |
| EP-0623134-A1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-11-09 | — | — | EP | disclosed |
| US-5252720-A | Medical uses | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-10-12 | — | — | US | disclosed |
| WO-1993014093-A1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-07-22 | — | — | WO | disclosed |
| US-4246052-A | REDUCED AND DIAZOTIZED TO FORM THE IGNITING AGENTS FOR PRIMERS AND EXPLOSIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | disclosed |
| US-4210498-A | CAMMA-PYRONES, NITRATED CATECHOLS, AND FLAVONES AS CHELATING AGENTS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1980-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120296123-A1 | FLUOROETHER-FUNCTIONALIZED NITROAROMATIC COMPOUNDS AND DERIVATIVES THEREOF | PFAS, PARG, PARN | GPR35 3412/4885HPGD 403/4885TSHR 4605/4885 |
| US-20120296122-A1 | FLUOROETHER-FUNCTIONALIZED AMINOAROMATIC COMPOUNDS AND DERIVATIVES THEREOF | PARG, PARN, AADAC | GPR35 3445/4885HPGD 1425/4885TSHR 4682/4885 |
| US-20240254317-A1 | DOPANT SOLUTION FOR CONDUCTIVE POLYMER, MONOMER LIQUID FOR PRODUCING CONDUCTIVE POLYMER, CONDUCTIVE COMPOSITION AND METHOD FOR PRODUCING SAME, AND ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING SAME | ADCY10, ADCY1, ADH1A | GPR35 690/4885HPGD 592/4885TSHR 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.